| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Chief Commercial Officer
1 company
Heerma Peter is a Chief Commercial Officer at Travere Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $8.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 4,195 | $8.53 | $35,788.80 | -4.0% | -30.2% | +137.9% | |
| Jan 23, 2024 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,559 | $9.07 | $14,137.64 | -1.9% | -37.0% | +109.5% | |
| Oct 3, 2023 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 3,091 | $8.25 | $25,504.15 | -3.7% | +11.8% | +62.2% | |
| Feb 1, 2023 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,779 | $21.75 | $38,696.81 | -2.1% | -29.2% | -61.1% | |
| Jan 24, 2023 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,550 | $21.90 | $33,951.82 | -2.4% | -2.9% | -58.3% | |
| Oct 4, 2022 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 3,042 | $25.68 | $78,118.56 | -4.5% | -20.6% | -69.8% | |
| Jan 31, 2022 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,125 | $27.40 | $30,825.00 | -1.6% | -6.4% | -18.5% | |
| Jan 24, 2022 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,875 | $24.98 | $46,837.50 | -3.1% | +9.9% | -16.2% | |
| Oct 4, 2021 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 3,058 | $24.77 | $75,746.05 | -4.8% | +22.7% | +4.3% | |
| Aug 17, 2021 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,407 | $17.12 | $24,086.01 | -2.2% | +48.9% | +40.8% |